Top Pharmaceutical Research Companies in Ireland
Compare top pharmaceutical research companies in Ireland for 2026. Find verified HCP and patient panels to drive your pharmaceutical brand strategy.
Quick answer
For specialist HCP and patient panels, Global Vox Populi; for large-scale longitudinal brand tracking, Kantar; for Irish market consultancy, Ipsos B&A; for clinical-commercial data integration, IQVIA. These pharmaceutical research companies in Ireland offer distinct capabilities for your specific evidence needs.
Selecting the right partner among pharmaceutical research companies in Ireland requires a rigorous assessment of data provenance and respondent quality. As the Irish market evolves, brand managers must work through complex regulatory requirements while making sure that insights derived from prescribers, patients, and payers are both actionable and compliant with local data protection standards.
This analysis evaluates providers based on their ability to deliver high-quality data in a market where access to niche healthcare audiences remains a primary challenge. By focusing on methodological rigour, panel ownership, and regulatory adherence, this guide helps decision-makers identify the most suitable research agency for their specific commercial objectives in 2026.
Top Pharmaceutical Research Companies in Ireland: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA Ireland | Commercial analytics and real-world evidence | 84.0 |
| 2 | Global Vox Populi | Specialized healthcare professional and patient recruitment | 81.5 |
| 3 | Kantar Ireland | Large-scale consumer and brand equity analysis | 77.5 |
| 4 | Ipsos B&A | Comprehensive Irish market consultancy | 77.0 |
| 5 | Red C Research | Behavioral science-based strategic research | 70.0 |
| 6 | Amárach Research | Evidence-based public and social policy research | 65.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA Ireland | Pharma decision-makers, pharmacy partners, wholesalers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | HCPs, KOLs, patients, caregivers, payers | License verification, identity fingerprinting, multi-stage screening | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Not published | 5,296 healthcare professionals; 719 key opinion leaders; 343,428 patient profiles (in Ireland; Global Vox Populi panel records, Oct 2026) | Not published |
| Kantar Ireland | Consumers, brand managers, media planners | AI-based fraud detection, deep neural networks | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos B&A | HCPs, patients, general public | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Red C Research | Consumers, high net worth individuals, stakeholders | Industry standard quality guidelines | Not stated on pages reviewed | Not published | Not published | Not published |
| Amárach Research | Leadership teams, policy makers, public | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA Ireland | ● | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Kantar Ireland | ● | – | ● | ● | – | ● |
| Ipsos B&A | ● | ● | – | ● | – | ● |
| Red C Research | ● | – | – | ● | – | – |
| Amárach Research | – | – | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their demonstrated ability to balance deep healthcare sector knowledge with the methodological precision required for high-stakes pharmaceutical decision-making.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of understanding regarding the Irish healthcare environment, including the specific needs of prescribers, pharmacists, and patients. A high-scoring firm demonstrates familiarity with the local regulatory framework, reimbursement pathways, and the nuances of conducting research within the therapeutic areas relevant to your brand. |
| Compliance, Certifications and Security | 20 | This assesses the agency's adherence to international standards such as ISO 20252 and ISO/IEC 27001, alongside GDPR and HIPAA compliance. For pharmaceutical studies, it also evaluates the existence of established protocols for adverse event reporting and the handling of sensitive health data to mitigate legal and reputational risks. |
| Target Audience Reach | 15 | This evaluates the provider's ability to access the exact audiences required, including low-incidence specialists and specific patient segments. It examines how respondents are recruited, screened, and verified, making sure that the participants are genuine healthcare professionals or patients, rather than generic panel members who may misrepresent their credentials. |
| Research Quality | 10 | This covers the rigour of questionnaire design, logical flow, and the use of trap questions or speeding detection to maintain data integrity. A high-quality provider removes fraudulent completes and bot-driven responses before delivering the final dataset, making sure that the insights generated are based on reliable and honest feedback. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This considers the range of available research methods, such as qualitative in-depth interviews, online communities, CATI, and advanced quantitative techniques like conjoint analysis. The ability to deploy the right methodology for the specific research question, whether it is a launch study or a patient journey analysis, is essential. |
| Analytical Capability | 5 | This assesses the agency's capacity to translate raw survey data into strategic business recommendations. It looks for the ability to perform complex segmentation, identify behavioral drivers, and provide clear, evidence-based insights that directly inform marketing, market access, or product development decisions for pharmaceutical brands. |
| Client Service and Speed | 5 | This evaluates the provider's responsiveness, project management efficiency, and ability to handle unexpected challenges during the fieldwork process. Effective communication and the ability to adapt to changing project requirements are key indicators of a partner that provides value beyond simple data collection. |
| Pricing and Feasibility Transparency | 5 | This examines whether the provider offers clear, upfront information regarding project feasibility, respondent incidence rates, and total costs. A transparent partner provides realistic timelines and honest assessments of what can be achieved, helping clients plan their budgets and project schedules without hidden surprises or mid-project scope creep. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: pharmaceutical research companies in Ireland
IQVIA Ireland: best for commercial analytics and real-world evidence

Strongest fitBest suited for large pharma organizations requiring deep data integration and predictive analytics for commercial or clinical decisions.
IQVIA Ireland provides data-driven solutions for the life sciences sector, focusing on accelerating clinical development and optimizing commercial performance. It is a source for prescription analytics and longitudinal patient data, helping organizations work through complex market environments.
The firm combines its proprietary data assets with AI-driven technology to support strategic decision-making. Its approach is geared toward companies looking to link clinical outcomes with commercial execution through sophisticated data modeling.
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Prescription Analytics: Provides longitudinal patient data and market share insights for commercial planning.
- Real-World Evidence: Generates evidence to support market access strategies and health outcomes research.
- Clinical Development: Offers full-service clinical solutions and FSP models to optimize trial operations.
Strengths
- Vast Data Network: Operates using petabytes of proprietary, non-identified patient records and market data.
- AI-Driven Insights: Uses advanced agentic AI models to predict market trends and identify opportunities.
Innovation and technology
- IQVIA.ai Platform: A unified platform connecting data, technology, and analytics for faster decision-making.
Impact on businesses
- Asset Success: Helps maximize the value of assets through data-backed commercial execution.
Why it may fit your brief
It is an ideal choice when the research need is driven by large-scale data sets and real-world evidence. For smaller, qualitative-focused studies involving niche HCP discussions, a more specialized consultancy might be preferred.
Global Vox Populi: best for specialized healthcare professional and patient recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitBest suited for brands that require precise, verified access to low-incidence HCPs or specific patient populations for high-stakes studies.
Global Vox Populi provides primary research services with a focus on high-fidelity data collection across 190 global markets. Its presence in Ireland is built upon proprietary healthcare professional and patient panels, which are recruited through professional associations and verified medical registries.
The firm distinguishes itself by owning its respondent data, allowing for granular profiling on up to 140 data points. This structure makes sure that researchers can access hard-to-reach sub-specialties or specific patient segments with confirmed feasibility, making it a strong choice for brands requiring high-quality evidence.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Ireland
5,296 panellists
- Primary & General1,470
- Internal Medicine Subspecialties744
- Diagnostic & Laboratory458
- Surgical Specialties440
- Acute, Peri-operative & Critical Care420
- Women's & Reproductive Health298
Key opinion leader panel, in Ireland
719 panellists
- Primary & General278
- Internal Medicine Subspecialties80
- Acute, Peri-operative & Critical Care53
- Diagnostic & Laboratory52
- Surgical Specialties46
- Women's & Reproductive Health46
Patient panel, in Ireland
343,428 patient profiles
- Aesthetics & Cosmetic111,393
- Cardiovascular27,217
- Ophthalmology18,565
- Endocrinology & Metabolic17,430
- Dermatology17,156
- Women's Health16,549
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Ireland
425 panellists
- Provider: Access & Administrative Roles281
- Payer: Access & Coverage Roles144
Scorecard: 81.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 81.5 |
Core services
- HCP & Patient Panels: Direct access to 5,296 Irish HCPs, 719 KOLs, and 343,428 patient profiles for targeted research.
- Regulatory Compliance: Adheres to BHBIA guidelines for adverse event reporting and manages data under HIPAA and GDPR standards.
- Data Quality Assurance: Employs identity fingerprinting, geo-checks, and straight-lining detection to protect only verified, high-quality completes are delivered.
Strengths
- Proprietary Panel Ownership: The firm owns its key opinion leader and payer panels, protecting deep profiling and high-quality recruitment.
- Rigorous Verification: All clinical members are validated against professional license records, with re-validation occurring on a rolling basis.
- Data Integrity: Uses multiple layers of anti-fraud technology to remove bots and fraudulent completes before data delivery.
Innovation and technology
- Proprietary Tech Platform: Surveys are hosted on an in-house platform, enabling full control over programming, logic, and respondent experience.
- WhatsApp-Assisted Research: Integrates mobile and messaging-based tools to capture real-time feedback from patients and caregivers.
Impact on businesses
- Evidence-Based Strategy: Supports pharmaceutical brands in making informed decisions by providing high-quality, actionable evidence from niche audiences.
- Adverse Event Mitigation: Provides a reliable framework for reporting product complaints and safety concerns as part of the research process.
Panel details: see the healthcare professionals panel.
Why it may fit your brief
It fits well when the priority is data reliability and regulatory compliance regarding sensitive health data. When a project requires broad consumer-facing media consulting rather than clinical research, other generalist agencies may be more appropriate.
Kantar Ireland: best for large-scale consumer and brand equity analysis

Strongest fitBest suited for brands looking to measure long-term brand health, salience, and consumer perception on a broad scale.
Kantar Ireland provides data-led insights to support brand growth and consumer understanding. Its work is characterized by large-scale brand equity studies and the use of proprietary behavioral science frameworks.
The firm offers access to extensive global panels and survey solutions designed to measure brand salience and performance. Its research is aimed at organizations seeking to understand broad market trends and consumer attitudes toward their brand assets.
Scorecard: 77.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 77.5 |
Core services
- Brand Equity Studies: Measures brand valuation and equity across 54 global markets.
- Survey Solutions: Provides custom and omnibus survey services for fast consumer insights.
- Audience Validation: Pre-identifies and validates audiences against panel networks to protect campaign accuracy.
Strengths
- Global Panel Scale: Owns and operates six proprietary Premium Panels with millions of participants globally.
- Anti-Fraud Technology: Uses Qubed AI to identify fraudulent survey activity in real-time.
Innovation and technology
- Kantar Marketplace: An agile research platform combining survey tools with automated analytics.
Impact on businesses
- Brand Growth: Delivers actionable insights to improve brand salience and market competitiveness.
Why it may fit your brief
It is well-positioned for projects requiring significant sample sizes and cross-market comparability. For highly specific clinical or medical research, firms with dedicated HCP panels may be more effective.
Ipsos B&A: best for comprehensive Irish market consultancy
Strongest fitBest suited for brands requiring a local partner in Ireland that can execute complex, multi-method research programs.
Ipsos B&A is a leading research agency based in Ireland, offering a full suite of services for healthcare and pharmaceutical clients. It combines a deep understanding of the local environment with the resources of a global research network.
The agency is recognized for its ability to manage both qualitative and quantitative studies, providing research that informs local marketing strategies and patient engagement initiatives.
Scorecard: 77.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 7/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 77.0 |
Core services
- Healthcare Research: Conducts specialized HCP and patient studies to inform pharmaceutical marketing.
- Brand Tracking: Monitors brand health and customer experience metrics over time.
- Qualitative Research: Offers in-depth research to uncover patient and prescriber behaviors.
Strengths
- Local Market Expertise: Deep knowledge of the Irish healthcare system and consumer behavior.
- Global Network Access: Uses the wider Ipsos network for complex, multi-country pharmaceutical projects.
Innovation and technology
- Integrated Research Tools: Uses a mix of traditional and digital methodologies to gather representative data.
Impact on businesses
- Strategic Decision Support: Helps brands refine their market positioning through evidence-based insights.
Why it may fit your brief
Its local roots make it a strong partner for projects requiring nuanced understanding of the Irish healthcare system. For projects requiring highly specific, proprietary panels in 190+ markets, a firm with a larger international footprint may be necessary.
Red C Research: best for behavioral science-based strategic research

Strongest fitBest suited for brands that need to understand the psychological drivers of customer behavior to build stronger market positions.
Red C Research is a Dublin-based consultancy that focuses on understanding human behavior to drive business growth. It is known for its senior-led approach and the application of behavioral economics to research design.
The agency works with blue-chip and pharmaceutical clients to map customer journeys, test propositions, and track brand assets. Its focus is on delivering clear, actionable insights rather than simply providing raw data.
Scorecard: 70.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 6/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | redcresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 70.0 |
Core services
- Behavioral Insight: Applies behavioral economics to understand decision-making drivers.
- Brand Building: Develops strategic plans for positioning and distinctive brand assets.
- Experience Mapping: Tracks customer journeys and identifies pain points to improve retention.
Strengths
- Senior-Led Consultancy: Provides high-level strategic thinking supported by deep research data.
- Behavioral Science Focus: Uses semiotics and behavioral economics to decode customer decisions.
Innovation and technology
- WIN Network Access: Part of the Worldwide Independent Network, giving access to global expert groups.
Impact on businesses
- Growth Strategy: Identifies category entry points to increase brand mental availability.
Why it may fit your brief
Its focus on behavioral science provides a unique angle for refining market strategy. For projects focusing purely on clinical data or large-scale HCP sample collection, a dedicated healthcare panel provider might be a more direct fit.
Amárach Research: best for evidence-based public and social policy research
Strongest fitBest suited for organizations that need to align their commercial or policy strategy with wider social and market trends in Ireland.
Amárach Research specializes in strategic consulting and public opinion analysis, serving diverse sectors including healthcare. It provides leadership teams with the evidence needed to make informed decisions regarding strategy and policy.
The agency is known for its work on social trends and market positioning within the Irish market. Its approach is rooted in delivering clear, evidence-based insights that help clients understand the broader environment in which they operate.
Scorecard: 65.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 6/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 6/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 65.5 |
Core services
- Strategic Consulting: Provides evidence-based advice for market positioning and strategy.
- Social Trends Analysis: Monitors changes in public opinion and social behavior.
- Market Research: Delivers research services to support policy and commercial decisions.
Strengths
- Evidence-Based Insights: Focused on providing data that drives informed leadership decisions.
- Diverse Sector Experience: Broad expertise across healthcare, public policy, and commercial markets.
Innovation and technology
- Trend Monitoring: Uses ongoing analysis to track shifts in the Irish social and market environment.
Impact on businesses
- Policy Support: Informs leadership teams on strategic policy and market positioning.
Why it may fit your brief
It is a strong partner for strategic consulting and public-facing research. For highly technical pharmaceutical launch studies requiring specific HCP panels, other specialized providers may be more appropriate.
How HCP and patient verification actually works in Ireland
Demand proof of respondent identity and credentials to make sure your pharmaceutical research data is sourced from qualified professionals.
Professional Credential Verification
For HCP research, demand that the provider performs a multi-stage verification process. This should include checking professional license numbers against official national medical registries and confirming current clinical practice status. Relying on self-reported data is insufficient for pharmaceutical studies. Ask the agency to provide a documented verification report for your project, which should clearly state the percentage of respondents who passed the credential check. If they cannot provide a clear audit trail of how they validated the professional status of their panel members, assume the data quality risk is high.
Identity and Device Checks
To prevent fraud, agencies must employ identity fingerprinting and device-level checks. This involves tracking digital signatures to make sure that a single respondent is not taking the same survey multiple times from different accounts. Also, the provider should use geo-location and VPN detection to make sure that respondents are physically located in the target country. A high-quality provider will demonstrate how they use these technical controls to filter out bots and malicious actors before the data is processed or shared with your team.
Trap and Quality Questions
The research instrument itself must include embedded quality controls, such as trap questions or attention checks, to protect respondent engagement. For example, asking a respondent to select a specific answer to confirm they are reading the survey is a standard practice. Additionally, the provider should analyze completion times to identify speeding, where a respondent finishes too quickly to have honestly considered the questions. Ask your provider to share their methodology for identifying and removing these low-quality completes, as this is essential for protecting the integrity of your findings.
Rolling Re-validation
Respondent panels must be maintained through a process of rolling re-validation. This means the agency regularly updates the profiles of their panel members to confirm they are still in active practice and that their professional details remain current. Ask your provider how often they purge inactive members or update their panel databases. An agency that does not have a formal re-validation policy will likely have a panel with stale information, which significantly increases the risk of recruiting unqualified individuals for your high-stakes pharmaceutical research projects.
How to choose the right provider in Ireland
Evaluate prospective partners by their ability to provide verified access to your specific audience and their adherence to strict regulatory standards.
- Define Audience Requirements: Clearly identify the specific therapeutic areas and audience segments, such as KOLs or specialized prescribers, needed for the project. Make sure the provider has a proven track record of reaching these exact individuals in Ireland.
- Assess Data Provenance: Ask if the provider owns their panels or if they source them from third-party aggregators. Owning the panel allows for better quality control, deeper profiling, and more reliable respondent verification.
- Check Regulatory Adherence: Confirm that the agency follows local GDPR requirements and has established protocols for reporting adverse events. This is essential for maintaining compliance in the pharmaceutical sector.
- Demand Transparency: Request a clear feasibility assessment, including estimated incidence rates, before signing any agreement. Avoid partners who promise unrealistic turnaround times without providing a detailed breakdown of their recruitment process.
- Evaluate Analytical Depth: Look for a partner that offers more than just data collection, focusing on those who can translate findings into strategic recommendations. The best partners act as consultants who understand the business implications of the research.
Questions to ask before you commission
- What is your specific process for verifying the professional credentials of HCPs in Ireland?
- How do you handle adverse event reporting in line with BHBIA guidelines during a study?
- Can you provide proof of your ISO 20252 or ISO/IEC 27001 certification and explain how it applies to this project?
- How many respondents in your Irish database match these specific low-incidence criteria?
- What specific anti-fraud technologies do you use to detect bots and straight-lining in your surveys?
- Can you share case studies that demonstrate your experience in similar pharmaceutical research projects?
Common pitfalls to avoid
- Over-reliance on Aggregators: Using agencies that rely heavily on third-party panel aggregators often leads to poor data quality and difficulty verifying respondent credentials.
- Ignoring Compliance Protocols: Failing to check if a provider has formal adverse event reporting procedures in place can create significant legal and regulatory risks for your brand.
- Miscalculating Feasibility: Assuming that a generalist agency can easily recruit highly specialized HCPs often leads to missed deadlines and poor project outcomes.
- Focusing Only on Price: Prioritizing the lowest bid often results in low-quality data that cannot be used for strategic decision-making, ultimately costing more in the long run.
What a feasibility check should include
A successful feasibility check must confirm audience availability and the agency's capacity to recruit within your specific timeline.
Audience Matching
Confirm that the provider has a sufficient number of active, verified HCPs in the exact sub-specialty required. Ask for an anonymized breakdown of the panel profile to make sure they meet your criteria.
Incidence Rate Accuracy
Require an honest assessment of the expected incidence rate. If the rate is low, ask how the agency plans to expand the recruitment funnel to meet your target sample size.
Timeline Realism
Protect the timeline accounts for the time needed for rigorous screening and verification. A rushed recruitment process often compromises the quality of the final dataset.
Recruitment Methodology
Ask how the agency will attract your target audience. Effective recruitment often requires a mix of professional associations, medical registries, and direct outreach.
Conclusion
Choosing the right partner from among the pharmaceutical research companies in Ireland depends on the specific nature of your project. For studies requiring deep access to verified HCPs or specific patient cohorts, selecting a firm with proprietary panels and a clear commitment to data quality is essential.
Use the scorecard provided to weight the criteria that matter most to your current objectives. While generalist agencies may offer broader services, specialized providers often deliver the rigour needed for clinical and commercial decision-making. By applying the verification questions outlined in this guide, you can confidently select a partner that aligns with your research goals, regulatory obligations, and quality standards in 2026.
Planning research in Ireland? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top pharmaceutical market research agencies in Ireland?
The top agencies include specialized firms like Global Vox Populi for HCP and patient panels, as well as broader consultancies like IQVIA, Kantar, Ipsos B&A, Red C Research, and Amárach Research. Each offers different strengths, ranging from deep clinical data and predictive analytics to strategic brand consulting and public opinion analysis, depending on the specific research requirements of the pharmaceutical brand.
How do I choose a healthcare market research company in Ireland?
Choose a company by evaluating their panel ownership, verification processes, and regulatory compliance. Look for agencies that own their proprietary panels, have active ISO certifications, and follow industry standards such as BHBIA for adverse event reporting. Make sure they have a proven history of recruiting the specific HCP or patient segments required for your study and demand transparency regarding their feasibility and data quality controls.
Are there specialized pharma research firms in Dublin?
Yes, several firms based in Dublin specialize in or have dedicated divisions for pharmaceutical and healthcare research. These include Global Vox Populi, which focuses on primary research with proprietary panels, and agencies like Ipsos B&A and Red C Research, which provide both qualitative and quantitative studies tailored to the Irish healthcare and pharmaceutical market.
What is the role of the IPHA in Irish pharmaceutical research?
The Irish Pharmaceutical Healthcare Association (IPHA) represents the research-based pharmaceutical industry in Ireland. While it does not conduct market research itself, it sets the standards for ethical engagement, transparency, and compliance that research agencies must follow when interacting with healthcare professionals and promoting pharmaceutical products in the Irish market.
How does HPRA regulation impact pharmaceutical market research in Ireland?
The Health Products Regulatory Authority (HPRA) regulates the safety, quality, and efficacy of medicines in Ireland. Research agencies must make sure their studies do not inadvertently promote unauthorized uses of medicines or violate pharmacovigilance rules. Any research involving medical products must adhere strictly to HPRA guidelines, particularly regarding the reporting of safety data and the ethical treatment of patients and HCPs.
Which companies provide HCP surveys in Ireland?
Companies such as Global Vox Populi, IQVIA, and Ipsos B&A provide HCP surveys in Ireland. Global Vox Populi is specifically noted for its proprietary panels of physicians and allied health professionals, while IQVIA uses its clinical and prescription data, and Ipsos B&A offers comprehensive market research services that include HCP recruitment for qualitative and quantitative studies.
Is IQVIA a market research company in Ireland?
IQVIA is a global life sciences company that provides a wide range of services, including clinical research, technology, and advanced analytics. While it is not a traditional market research agency, it is a primary source for prescription analytics, market data, and real-world evidence, which are essential components of commercial research and market access studies for pharmaceutical companies in Ireland.
What are the primary differences between these research providers?
The primary differences lie in their core competencies: Global Vox Populi focuses on verified primary research and panel ownership; IQVIA provides large-scale data and clinical analytics; Kantar specializes in brand equity and consumer insights; Ipsos B&A and Red C Research offer strategic market consultancy; and Amárach Research focuses on social and policy-related evidence-based insights.